Issue |
BIO Web Conf.
Volume 41, 2021
The 4th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2021)
|
|
---|---|---|
Article Number | 07002 | |
Number of page(s) | 7 | |
Section | Drug Development and Nutraceutical | |
DOI | https://doi.org/10.1051/bioconf/20214107002 | |
Published online | 22 December 2021 |
In silico molecular docking and molecular dynamics examination of Andrographis paniculata compounds of Andrographolide, Neoandrographolide, and 5-hydroxy-7,8,2’,3’-tetramethoxyflavone inhibition activity to SARS-CoV-2 main protease
1
Department of Metallurgical and Materials Engineering, Faculty of Engineering, University of Indonesia, Depok, Jawa Barat, Indonesia, 16424
2
Department of Medicine Chemistry, Faculty of Medicine, University of Indonesia, Salemba, Jakarta, Indonesia, 10430
3
Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Negeri Semarang, Semarang 50229
* Corresponding author: jakafajar@ui.ac.id
In this work, Andrographis paniculata compounds of Andrographolide, Neoandrographolide, and 5-hydroxy-7,8,2’,3’-tetramethoxyflavone inhibition activity to SARS CoV-2 main protease were examined through in silico molecular docking and molecular dynamics simulation, with Remdesivir as control ligand. Docking score and MMGBSA were examined as well as molecular dynamics parameters: RMSD, RMSF and Protein ligand contact fraction. Our study found that Andrographis paniculata compounds of Andrographolide, Neoandrographolide, and 5-hydroxy-7,8,2’,3’-tetramethoxyflavone have comparable inhibition activity to SARS CoV-2 main protease in comparison to Remdesivir. 5-hydroxy7,8,2’,3’-tetramethoxyflavone has the lowest docking score, which was further validated by protein ligand contact fraction examination, although MMGBSA score is lowest for Remdesivir.
Key words: In silico molecular docking / molecular dynamics / SARS-CoV-2 / Andrographis paniculata / Remdesivir
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.